What are Idexx Laboratories's total assets?

Idexx Laboratories (IDXX) holds $3.4B in total assets, up 5.3% year over year.

How much debt does Idexx Laboratories have?

Idexx Laboratories carries $575.5M in total debt against $1.6B of shareholders' equity, a debt-to-equity ratio of 0.37.

How much cash does Idexx Laboratories have?

Idexx Laboratories holds $200.5M in cash and equivalents.

Can Idexx Laboratories cover its short-term obligations?

Its current ratio is 1.12 — current assets exceed current liabilities.

Where does Idexx Laboratories's balance sheet data come from?

Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Idexx Laboratories IDXX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$200.53M+22.3%	$180.07M-37.5%	$208.17M-32.6%	$164.59M-59.0%	$163.97M-58.7%
Accounts receivable, net	$603.54M+14.4%	$552.38M+16.6%	$566.88M+10.9%	$560.56M+5.1%	$527.46M+4.0%
Inventories	$382.4M-3.4%	$377.76M-1.1%	$391.56M+0.5%	$392.58M+3.3%	$395.99M+1.4%
Raw materials	$98.4M-6.0%	$96.3M-7.6%	$102.5M-4.1%	$104.06M0.0%	$104.71M+1.6%
Work in process	$34.14M-2.5%	$32.59M+2.1%	$33.97M+4.9%	$35.11M+9.6%	$35M+24.0%
Finished goods	$249.86M-2.5%	$248.87M+1.3%	$255.1M+1.8%	$253.41M+3.9%	$256.27M-1.2%
Prepaid expenses and other current assets	$76.86M+23.6%	$73.56M-71.3%	$70.01M+19.7%	$66.69M+11.8%	$62.21M+14.2%
Income taxes receivable	$15.97M+16.1%	$64.99M+141%	$76.13M+429%	$35M+119%	$13.76M-4.9%
Contract assets	$77.7M+23.5%	$75.83M+24.8%	$71.95M+17.2%	$67.91M+15.7%	$62.93M+11.2%
Total current assets	$1.45B+10.4%	$1.41B+1.0%	$1.48B+3.0%	$1.36B-10.9%	$1.32B-12.3%
Property and equipment, net	$740.38M+3.2%	$747.38M+4.8%	$739.44M+3.0%	$739.68M+4.4%	$717.62M+1.3%
Operating lease right-of-use assets	$121.4M+4.7%	$123.23M+6.1%	$128.21M+5.9%	$129.78M+8.6%	$116M-3.2%
Goodwill	$412.1M+1.1%	$414M+2.2%	$413.65M+0.4%	$414.49M+1.6%	$407.49M-0.3%
Intangible assets, net	$104.75M-2.5%	$109.84M-1.6%	$114.79M+7.4%	$103.73M-6.4%	$107.41M-6.9%
Other non-current assets	$47.27M+15.2%	$42.64M-2.6%	$38.98M-26.5%	$39.54M-17.2%	$41.02M-19.3%
Equity securities	$27.56M-11.1%	$31.76M+2.4%	$31.76M+5.9%	$31M—	$31M—
Total noncurrent assets	$1.93B+1.9%	$1.94B+2.3%	$1.91B-0.4%	$1.97B+4.4%	$1.9B+2.4%
Total assets	$3.39B+5.3%	$3.35B+1.7%	$3.39B+1.1%	$3.33B-2.5%	$3.21B-4.2%
Accounts payable	$129.97M+8.2%	$110.41M-3.3%	$122.27M+10.5%	$116.59M-0.8%	$120.1M+2.2%
Accrued expenses	$144.62M+18.3%	$212.44M-57.7%	$192.52M+21.1%	$140.92M+13.6%	$122.23M+5.1%
Deferred revenue	$36.33M+3.8%	$35.26M+4.3%	$35.69M-7.1%	$36.32M-4.4%	$35M-8.4%
Current portion of long-term debt	$150M-12.2%	$75M-55.3%	$150M+51.3%	$74.99M-55.9%	$170.93M+128%
Operating lease liabilities, current	$26.85M+21.4%	$27.07M+25.7%	$26.65M+27.1%	$25.83M+28.8%	$22.13M+14.7%
Contract liabilities	$32.31M+20.5%	$32.18M+19.4%	$31.05M+16.0%	$31.76M+18.6%	$26.82M-4.4%
Income taxes payable	$80.03M-21.5%	$88.67M+42.4%	$89.2M+11.4%	$75.21M-48.6%	$101.93M-24.0%
Other current liabilities	$0—	$0—	$0—	$0—	$0—
Total current liabilities	$1.3B+14.4%	$1.15B+7.6%	$1.25B+24.0%	$1.22B+9.6%	$1.14B+18.7%
Long-term debt	$299.85M-33.3%	$374.84M-16.7%	$374.83M-28.6%	$449.81M-14.3%	$449.8M-27.5%
Operating lease liabilities, non-current	$98.75M+1.8%	$101.15M+3.4%	$106.49M+3.0%	$107.64M+4.5%	$97M-6.6%
Operating Lease Liabilities (Total)	$125.6M+5.4%	$128.23M+7.4%	$133.14M+7.0%	$133.47M+8.5%	$119.13M-3.3%
Other non-current liabilities	$54.03M+13.2%	$56.53M+27.5%	$57.62M-8.4%	$56.79M+6.4%	$47.73M-28.0%
Total noncurrent liabilities	$529.54M-15.9%	$596.56M-5.3%	$573.72M-20.7%	$648.09M-9.7%	$629.46M-24.0%
Total liabilities	$1.83B+3.6%	$1.75B+2.8%	$1.83B+5.4%	$1.87B+2.0%	$1.77B-1.1%
Common stock	120M0.0%	120M+1,013%	120M0.0%	120M0.0%	120M0.0%
Additional paid-in capital	$1.86B+9.8%	$1.83B+9.1%	$1.79B+8.9%	$1.73B+6.3%	$1.7B+5.7%
Retained earnings	$6.67B+19.6%	$6.39B+19.9%	$6.14B+20.1%	$5.87B+20.2%	$5.58B+19.1%
Accumulated other comprehensive income (loss)	-$64.94M+27.9%	-$68.84M+26.5%	-$72.95M+4.0%	-$76.95M+9.7%	-$90.09M-12.1%
Treasury stock	$6.93B+20.5%	$6.56B+23.0%	$6.32B+24.3%	$6.08B+25.1%	$5.75B+23.6%
Total stockholders' equity	$1.56B+7.5%	$1.61B+0.6%	$1.56B-3.5%	$1.46B-7.7%	$1.45B-7.7%
Total liabilities and stockholders' equity	$3.39B+5.3%	$3.35B+1.7%	$3.39B+1.1%	$3.33B-2.5%	$3.21B-4.2%
Allowance for Doubtful Accounts	$14.3M+12.6%	$11.3M-10.3%	$11.7M-5.6%	$12.2M-0.8%	$12.7M+19.8%
Allowance for Doubtful Accounts Receivable (Current)	$14.3M+12.6%	$11.3M-10.3%	$11.7M-5.6%	$12.2M-0.8%	$12.7M+19.8%
Finished goods	$249.86M-2.5%	$248.87M+1.3%	$255.1M+1.8%	$253.41M+3.9%	$256.27M-1.2%
Other current assets	$267.6M+16.3%	$303.62M+18.5%	$310.44M+38.6%	$244.62M+14.6%	$230.19M+11.3%
Capitalized Contract Costs, Net	$21.3M-6.6%	$21.4M-2.7%	$21.5M+4.4%	$21.5M+9.7%	$22.8M+15.7%
Contract Assets, Non-Current	$240.96M+26.9%	$236.91M+27.7%	$216.78M+16.6%	$206.88M+14.8%	$189.88M+9.5%
Deferred Tax Assets and Other Non-Current Assets	$552.79M+1.0%	$542.48M-0.9%	$513.57M-8.2%	$580.77M+7.6%	$547.56M+9.8%
Net Investment in Lease	$121.4M+4.7%	$123.23M+6.1%	$128.21M+5.9%	$129.78M+8.6%	$116M-3.2%
Deferred contract costs	$187.71M+38.5%	$176.58M+30.9%	$167.26M+28.2%	$151.03M+14.5%	$135.57M+19.2%
Deferred tax assets	$23.27M-81.1%	$27.87M-77.8%	$31.5M-76.6%	$125.02M-0.8%	$123.08M+15.6%
Other intangible assets—net	$104.75M-2.5%	$109.84M-1.6%	$114.79M+7.4%	$103.73M-6.4%	$107.41M-6.9%
Operating lease right-of-use assets	$121.4M+4.7%	$123.23M+6.1%	$128.21M+5.9%	$129.78M+8.6%	$116M-3.2%
Other non-current assets	$552.79M+1.0%	$542.48M-0.9%	$513.57M-8.2%	$580.77M+7.6%	$547.56M+9.8%
Operating Lease Right-of-Use Assets in Other Assets	$121.4M+4.7%	$123.23M+6.1%	$128.21M+5.9%	$129.78M+8.6%	$116M-3.2%
Prepaid Expenses, Non-Current	$26.03M-3.6%	$26.72M0.0%	$27.31M+8.2%	$27.3M+14.7%	$27M+10.7%
Software and Technology Licenses, Net	$552.79M+1.0%	$542.48M-0.9%	$513.57M-8.2%	$580.77M+7.6%	$547.56M+9.8%
Accrued Manufacturing Costs	$144.62M+18.3%	$212.44M+21.7%	$192.52M+21.1%	$140.92M+13.6%	$122.23M+5.1%
Accrued Marketing and Advertising Expenses	$89.6M+19.7%	$87.63M+12.1%	$86.39M+14.2%	$84.97M+1.4%	$74.86M-7.4%
Accrued Progress Collections and Price Adjustments	$32.31M+20.5%	$32.18M+19.4%	$31.05M+16.0%	$31.76M+18.6%	$26.82M-4.4%
Other Commercial Liabilities	$453.55M-7.6%	$530.15M+5.6%	$488.86M-4.3%	$416.98M-22.9%	$490.69M+3.0%
Accrued Income Taxes, Current	$80.03M-21.5%	$88.67M+42.4%	$89.2M+11.4%	$75.21M-48.6%	$101.93M-24.0%
Accrued Liabilities, Current	$453.55M-7.6%	$530.15M+5.6%	$488.86M-4.3%	$416.98M-22.9%	$490.69M+3.0%
Compensation and benefits	$144.62M+18.3%	$212.44M+21.7%	$192.52M+21.1%	$140.92M+13.6%	$122.23M+5.1%
Revolving credit facility	$530M+65.9%	$398M+59.2%	$455M+82.0%	$579M+132%	$319.5M+27.8%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——	——
Line of Credit Outstanding	$530M+65.9%	$398M+59.2%	$455M+82.0%	$579M+132%	$319.5M+27.8%
Operating Lease Liability Payments Due	——	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——	——
Supplier Finance Program Obligations	683,600,000%-182,500,000%	624,900,000%+28,200,000%	724,500,000%+174,100,000%	723,700,000%-151,000,000%	866,100,000%-173,900,000%
Contingent Consideration Liability (Non-Current)	——	——	——	——	——
Contract Liabilities, Non-Current	$32.31M+20.5%	$32.18M+19.4%	$31.05M+16.0%	$31.76M+18.6%	$26.82M-4.4%
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——	——
Marketing and selling	$89.6M+19.7%	$87.63M+12.1%	$86.39M+14.2%	$84.97M+1.4%	$74.86M-7.4%
Deferred revenue, net of current portion	$32.31M+20.5%	$32.18M+19.4%	$31.05M+16.0%	$31.76M+18.6%	$26.82M-4.4%
Common Stock Par Value Per Share	$0.100.0%	$0.100.0%	$0.100.0%	$0.100.0%	$0.100.0%
Common Stock Shares Issued	108.5M+0.5%	108.4M+0.5%	108.3M+0.6%	108M+0.3%	107.9M+0.2%
Additional paid-in capital	$1.86B+9.8%	$1.83B+9.1%	$1.79B+8.9%	$1.73B+6.3%	$1.7B+5.7%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$10.85M+0.5%	$10.84M+0.5%	$10.83M+0.6%	$10.8M+0.3%	$10.79M+0.2%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——	——
Percent of accounts receivable not past due (as a percent)	88%+2.0%	87%+2.0%	88%+5.0%	88%+8.0%	86%+2.0%
Percent of accounts receivable past due (as a percent)	12%-2.0%	13%-2.0%	12%-5.0%	12%-8.0%	14%-2.0%
Income taxes payable – long-term	$14.54M-35.8%	$14.45M-30.8%	$14.78M-51.5%	$14.11M-50.8%	$22.66M-43.4%
Accounts Receivable, Allowance for Credit Loss	$14.3M+12.6%	$11.3M-10.3%	$11.7M-5.6%	$12.2M-0.8%	$12.7M+19.8%
Business Combination, Contingent Consideration, Liability	——	——	——	——	——
Capitalized Contract Cost, Net	$21.3M-6.6%	$21.4M-2.7%	$21.5M+4.4%	$21.5M+9.7%	$22.8M+15.7%
Common shares outstanding (in shares)	60K+1.7%	59K-1.7%	60K0.0%	60K0.0%	59K0.0%
Deferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025	$6.17M+5.3%	$6.09M+3.6%	$6.23M+5.8%	$6.23M+5.8%	$5.86M+6.3%
Common stock, par value (in dollars per share)	$0.10.0%	$0.10.0%	$0.10.0%	$0.10.0%	$0.10.0%
Common stock, shares authorized (in shares)	$120M0.0%	$120M0.0%	$120M0.0%	$120M0.0%	$120M0.0%
Common stock, shares issued (in shares)	$108.5M+0.5%	$108.37M+0.5%	$108.3M+0.6%	$108.04M+0.3%	$107.92M+0.2%
Common Stock, Shares, Outstanding	$79.24M-1.9%	$79.71M-2.3%	$80M-2.5%	$80.15M-2.8%	$80.74M-2.6%
Reserve for contract assets and sales-type leases	$8.8M+25.7%	$8.6M+26.5%	$8M+14.3%	$7.6M+13.4%	$7M+6.1%
Other contract costs	$76.86M+23.6%	$73.56M+19.3%	$70.01M+19.7%	$66.69M+11.8%	$62.21M+14.2%
Deferred income taxes	$44.6M+450%	$31.87M+182%	$3.72M-34.2%	$2.09M-79.2%	$8.11M-7.3%
Unrecognized compensation cost related to non-vested awards	——	——	——	——	——
Guarantor obligations, current carrying value	$0—	$0—	$0—	$0—	$0—
Tax receivable within other current assets	$15.97M+16.1%	$64.99M+141%	$76.13M+429%	$35M+119%	$13.76M-4.9%
Lessee Operating Lease Liability Payments Due	——	——	——	——	——
Thereafter	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——	——
Other accrued liabilities	$112.45M-33.7%	$114.33M-30.9%	$94.11M-46.3%	$90.05M-46.1%	$169.54M+35.0%
Other	$32.73M-13.8%	$31.35M-34.9%	$31.53M-3.0%	$28.8M-11.9%	$37.95M+13.1%
Prepaid expenses	$64.35M+20.6%	$57.9M-1.2%	$60.82M+6.3%	$46.22M-0.5%	$53.34M+12.0%
Accrued settlement liabilities	——	——	——	——	——
Supplier finance program, obligation	$6.84M-21.1%	$6.25M+4.7%	$7.25M+31.6%	$7.24M-17.3%	$8.66M-16.7%
Treasury stock, shares (in shares)	$29.26M+7.7%	$28.66M+9.2%	$28.3M+10.3%	$27.89M+10.6%	$27.18M+9.6%
Unrecorded Unconditional Purchase Obligation	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Idexx Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Idexx Laboratories's total assets?: Idexx Laboratories (IDXX) holds $3.4B in total assets, up 5.3% year over year.
How much debt does Idexx Laboratories have?: Idexx Laboratories carries $575.5M in total debt against $1.6B of shareholders' equity, a debt-to-equity ratio of 0.37.
How much cash does Idexx Laboratories have?: Idexx Laboratories holds $200.5M in cash and equivalents.
Can Idexx Laboratories cover its short-term obligations?: Its current ratio is 1.12 — current assets exceed current liabilities.
Where does Idexx Laboratories's balance sheet data come from?: Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.